| CASI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CASI shares outstanding history going back to 7/1/2010:
Also see: CASI Market Cap History CASI YTD Return |
CASI Shares Outstanding History — CASI Pharmaceuticals Share Count Over Time
As of 11/8/2022 CASI Pharmaceuticals has 13.61 million CASI shares outstanding. Investors often track the CASI shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CASI share count trends over time, with 53 historical shares outstanding datapoints presented, dating back to 7/1/2010.
| CASI Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CASI Historical Shares Outstanding: +24.31% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CASI Stock Price Chart |
| About CASI Pharmaceuticals Inc (New) |
| CASI Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world. Co. is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its commercial product, EVOMELA, is an intravenous formulation of melphalan commercialized by Acrotech in the multiple myeloma treatment setting in the U.S.. Its pipeline products include CNCT19 (CD19 CAR-T), BI-1206 (anti- FcYRIIB antibody), CB-5339 (VCP/p97 inhibitor), CID-103 (Anti-CD38 Mab), Thiotepa, and Octreotide LAI. We show 53 historical shares outstanding datapoints in our coverage of CASI's shares outstanding history. Understanding the changing numbers of CASI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CASI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CASI by allowing them to research CASI shares outstanding history as well as any other stock in our coverage universe. |
| CASI Current Stock Quote |
Quotes delayed 20 minutes  Free CASI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CASI Share Performance |
| Shares Outstanding Peers |
| CASI Pharmaceuticals (CASI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CASM Shares Outstanding History CATB Shares Outstanding History CATS Shares Outstanding History CBAY Shares Outstanding History CBIO Shares Outstanding History CBLI Shares Outstanding History CBM Shares Outstanding History CBMG Shares Outstanding History CBPO Shares Outstanding History CBUS Shares Outstanding History More Healthcare companies » |
CASI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
